Carrie, C., Hasbini, A., de Laroche, G., Richaud, P., Guerif, S., Latorzeff, I., Supiot, S., Bosset, M., Lagrange, J., Beckendorf, V., Lesaunier, F., Dubray, B., Wagner, J., N'Guyen, T. D., Suchaud, J., Créhange, G., Barbier, N., Habibian, M., Ferlay, C., Fourneret, P., Ruffion, A., & Dussart, S. (n.d.). salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet oncology, 17(6), 747–756. http://access.bl.uk/ark:/81055/vdc_100032476377.0x000053